Evidence map›Paper›PMID 32259102›Full record

ArticleAdvances in pharmacological and pharmaceutical sciences2020

Physiological and Biochemical Vascular Reactivity Parameters of Angiotensin II and the Action of Biased Agonist TRV023.

Marcos André Soares Leal, Thanisia de Almeida, João Guilherme Torres, Luciene Cristina Gastalho Campos, Elisardo Corral Vasquez, Valério Garrone Barauna

Open access · goldAbstract read
In one paragraph

Article in Advances in pharmacological and pharmaceutical sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 57% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Marcos André Soares LealLaboratory of Translational Physiology, Federal University of Espirito, Vitória, Espirito Santo, Brazil.
Thanisia de AlmeidaLaboratory of Molecular Physiology, Federal University of Espírito Santo, Vitória, Espirito Santo, Brazil.
João Guilherme TorresPostgraduate Program in Biochemistry, Federal University of the Pampa, Uruguaiana, RS, Brazil.
Luciene Cristina Gastalho CamposDepartment of Biological Science, Santa Cruz State University, Ilheus, BA, Brazil.
Elisardo Corral VasquezLaboratory of Translational Physiology, Federal University of Espirito, Vitória, Espirito Santo, Brazil.ORCID https://orcid.org/0000-0003-1186-5168
Valério Garrone BaraunaLaboratory of Molecular Physiology, Federal University of Espírito Santo, Vitória, Espirito Santo, Brazil.ORCID https://orcid.org/0000-0001-9217-6000
Universidade Federal do Espírito Santo · BRUniversidade Estadual de Santa Cruz · BRUniversidade Federal do Pampa · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vascular reactivity experiments using isolated aortic rings have been widely used as a model for physiological and pharmacological studies since the early sixties. Here, we suggest several parameters that the researcher should pay attention to when investigating angiotensin II in their experimental models. Angiotensin II is one of the active peptides of the renin-angiotensin system and exerts its effect through the AT1 and AT2 receptors. Some studies seek to understand the effects of angiotensin II receptors at the vascular level by using vascular reactivity experiments. However, because of the large number of variations, there are only a handful of reactivity studies that seek to use this method. Thus, the objective of this study was to standardize experimental methods with angiotensin II, through vascular reactivity protocols. For this, variables such as basal tension, concentration interval, single concentration, curve concentration response, and multiple experiments using the same aortic ring were developed using the technique of vascular reactivity in an organ bath. This is the first study that has standardized the vascular reactivity protocol. In addition, we demonstrated the effects of TRV023-biased ligand of the AT1R at vascular sites.

Identifiers

PMID32259102
PMCPMC7094174
OpenAlexW3008448078

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.